RepliCel Life Sciences Inc. (REPCF)
REPCF Stock Price Chart
Explore RepliCel Life Sciences Inc. interactive price chart. Choose custom timeframes to analyze REPCF price movements and trends.
REPCF Company Profile
Discover essential business fundamentals and corporate details for RepliCel Life Sciences Inc. (REPCF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
3 May 2010
Employees
—
Website
https://www.replicel.comCEO
Andrew Schutte
Description
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01 for the treatment of chronic tendinosis; RCS-01 to treat aging and sun damaged skin; and RCH-01 for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.
REPCF Financial Timeline
Browse a chronological timeline of RepliCel Life Sciences Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 4 Aug 2025
Earnings released on 19 May 2025
EPS came in at $0.01 , while revenue for the quarter reached $61.45K .
Earnings released on 31 Mar 2025
EPS came in at -$0.08 .
Earnings released on 26 Nov 2024
EPS came in at -$0.00 , while revenue for the quarter reached $65.16K .
Earnings released on 6 Aug 2024
EPS came in at -$0.00 , while revenue for the quarter reached $64.68K , missing expectations by -53.80%.
Earnings released on 30 May 2024
EPS came in at -$0.00 , while revenue for the quarter reached $65.12K , missing expectations by -53.48%.
Earnings released on 1 May 2024
EPS came in at $0.02 , while revenue for the quarter reached $66.58K .
Earnings released on 28 Nov 2023
EPS came in at -$0.01 , while revenue for the quarter reached $65.29K , missing expectations by -53.36%.
Earnings released on 22 Sept 2023
EPS came in at -$0.01 , while revenue for the quarter reached $66.76K , missing expectations by -52.32%.
Earnings released on 30 May 2023
EPS came in at -$0.01 , while revenue for the quarter reached $65.35K .
Earnings released on 19 Apr 2023
EPS came in at $0.04 , while revenue for the quarter reached $65.91K .
Earnings released on 29 Nov 2022
EPS came in at -$0.02 , while revenue for the quarter reached $64.58K .
Earnings released on 6 Sept 2022
EPS came in at -$0.03 , while revenue for the quarter reached $68.66K .
Earnings released on 28 Jun 2022
EPS came in at -$0.02 , while revenue for the quarter reached $69.35K .
Earnings released on 31 Mar 2022
EPS came in at -$0.02 , while revenue for the quarter reached $70.74K .
Earnings released on 30 Nov 2021
EPS came in at -$0.02 , while revenue for the quarter reached $69.76K .
Earnings released on 30 Jun 2021
EPS came in at -$0.03 , while revenue for the quarter reached $71.35K .
Earnings released on 1 Jun 2021
EPS came in at -$0.04 , while revenue for the quarter reached $70.36K .
Earnings released on 17 May 2021
EPS came in at -$0.01 , while revenue for the quarter reached $69.27K .
Earnings released on 30 Nov 2020
EPS came in at -$0.02 , while revenue for the quarter reached $66.42K .
Earnings released on 15 Oct 2020
EPS came in at -$0.01 , while revenue for the quarter reached $46.55K .
REPCF Stock Performance
Access detailed REPCF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.